Study Shows Long-term Benefits of TAVR Over Medical Therapy
The minimally invasive procedure to replace a diseased aortic valve is proving to be a durable solution for high-risk patients.
Patients who have a stiff aortic valve replaced using a catheter procedure have better outcomes after five years than similar patients who undergo a catheter procedure that simply uses a small balloon to open the valve’s leaflets. Those are the findings of a Cleveland Clinic study published recently in The Lancet. Led by Samir Kapadia, MD, director of the Sones Cardiac Catheterization Laboratories at Cleveland Clinic, the study further supports the use of a promising new procedure called transcatheter aortic valve replacement (TAVR). It’s an option for patients who are too frail for open heart surgery. “This trial is the first—and will probably be the only—randomized aortic stenosis trial that includes a group of patients not treated with aortic valve replacement, since these results will make it unethical to treat severe stenosis patients with medical therapy alone,” Dr. Kapadia says.